Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

Author(s):
Roth, D.; Nelson, D.R.; Bruchfeld, A.; Liapakis, A.; Silva, M.; Monsour, H.; Martin, P.; Pol, S.; Londono, M.C.; Hassanein, T.; Zamor, P.J.; Zuckerman, E.; Wan, S.; Jackson, B.; Nguyen, B.Y.; Robertson, M.; Barr, E.; Wahl, J.; Greaves, W.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-10-17
Language
English
Is part of
Lancet (2015), Vol. 386, no. 10003, p. 1537-1545
hdl
1887/117492
doi
10.1016/S0140-6736(15)00349-9